Company News

Bayer To Buy Merck’s Consumer Care Unit

Coppertone and other well-known OTC brands find new home in $14.2 billion deal.

Author Image

By: Christine Esposito

Editor-in-Chief

Merck has entered into a definitive agreement to sell its its consumer care business to Bayer AG for $14.2 billion. Under the terms of the agreement, Bayer will acquire Merck’s existing OTC business, which includes the global trademark and prescription rights for products like Claritin and Afrin, as well as the company’s venerable Coppertone sun care brand, Lotrimin OTC itch products and Dr. Scholl’s footcare.   “Merck Consumer Care is a strong business with a portfolio of well-establishe...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters